Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine

Development of Neutralizing Monoclonal Antibodies for Oncogenic Human Papillomavirus Types 31, 33, 45, 52, and 58

(2014) Martha J. Brown et al.   Clinical and Vaccine Immunology

Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomaviruse types 16 and 18

(2014) Darron Brown et al.   VACCINE

Comments on ‘Sample size for equivalence trials: a case study from a vaccine lot consistency trial’ by J. Ganju, A. Izu and A. Anemona

(2012) Xiao Sun et al.   STATISTICS IN MEDICINE

Human Papillomavirus Vaccines – Immune Responses

(2012) Margaret Stanley et al.   VACCINE

Food and Drug Administration Regulation and Evaluation of Vaccines

(2011) V. Marshall et al.   PEDIATRICS

Sample size for equivalence trials: A case study from a vaccine lot consistency trial

(2008) Jitendra Ganju et al.   STATISTICS IN MEDICINE